pI: 4.8515 |
Length (AA): 241 |
MW (Da): 26484 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127623)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G35590 | proteasome alpha subunit A1 |
Babesia bovis | BBOV_II002330 | proteasome subunit alpha type 6 protein, putative |
Brugia malayi | Bm1_05700 | proteasome subunit alpha type 6 |
Candida albicans | CaO19.12833 | proteasome subunit |
Candida albicans | CaO19.5378 | proteasome subunit |
Caenorhabditis elegans | CELE_C15H11.7 | Protein PAS-1 |
Cryptosporidium hominis | Chro.30255 | proteasome subunit alpha type 6 (20S proteasome alpha subunit A) (20S proteasome subunit alpha-1) (Proteasome iota subunit) |
Cryptosporidium hominis | Chro.30254 | 20S proteasome subunit PAA1 |
Cryptosporidium parvum | cgd3_2170 | proteasome subunit alpha1 |
Dictyostelium discoideum | DDB_G0278847 | 20S proteasome subunit alpha-6 |
Drosophila melanogaster | Dmel_CG18495 | Proteasome alpha1 subunit |
Drosophila melanogaster | Dmel_CG30382 | CG30382 gene product from transcript CG30382-RB |
Echinococcus granulosus | EgrG_000877400 | proteasome subunit alpha type 6 |
Entamoeba histolytica | EHI_153190 | proteasome subunit alpha type 6, putative |
Echinococcus multilocularis | EmuJ_000877400 | proteasome subunit alpha type 6 |
Giardia lamblia | GL50803_16924 | 20S proteasome alpha subunit 1 |
Homo sapiens | ENSG00000100902 | proteasome (prosome, macropain) subunit, alpha type, 6 |
Leishmania braziliensis | LbrM.34.4810 | proteasome alpha 1 subunit, putative |
Leishmania donovani | LdBPK_354910.1 | proteasome alpha 1 subunit, putative |
Leishmania infantum | LinJ.35.4910 | proteasome alpha 1 subunit, putative |
Leishmania major | LmjF.35.4850 | proteasome alpha 1 subunit, putative |
Leishmania mexicana | LmxM.34.4850 | proteasome alpha 1 subunit, putative |
Loa Loa (eye worm) | LOAG_03012 | proteasome subunit alpha type 6 |
Mus musculus | ENSMUSG00000021024 | proteasome (prosome, macropain) subunit, alpha type 6 |
Neospora caninum | NCLIV_017470 | Proteasome subunit alpha type (EC 3.4.25.1), related |
Oryza sativa | 4331828 | Os03g0180400 |
Plasmodium berghei | PBANKA_1223100 | proteasome subunit alpha type-6, putative |
Plasmodium falciparum | PF3D7_0807500 | proteasome subunit alpha type-6, putative |
Plasmodium knowlesi | PKNH_0111300 | proteasome subunit alpha type-6, putative |
Plasmodium vivax | PVX_088170 | proteasome subunit alpha type-6, putative |
Plasmodium yoelii | PY04190 | proteasome subunit alpha Type 6-B |
Saccharomyces cerevisiae | YGL011C | proteasome core particle subunit alpha 1 |
Schistosoma japonicum | Sjp_0204320 | ko:K02730 20S proteasome subunit alpha 1, putative |
Schistosoma japonicum | Sjp_0023990 | ko:K04715 ceramide kinase [EC2.7.1.138], putative |
Schistosoma mansoni | Smp_130110 | proteasome subunit alpha 6 (T01 family) |
Schmidtea mediterranea | mk4.000779.07 | Proteasome subunit alpha 6 |
Trypanosoma brucei gambiense | Tbg972.9.5530 | proteasome alpha 1 subunit, putative,20S proteasome subunit alpha-6, (putative) |
Trypanosoma brucei | Tb927.9.9670 | proteasome alpha 1 subunit, putative |
Trypanosoma congolense | TcIL3000_9_3500 | proteasome alpha 1 subunit, putative |
Trypanosoma cruzi | TcCLB.510729.70 | proteasome alpha 1 subunit, putative |
Trypanosoma cruzi | TcCLB.506885.350 | proteasome alpha 1 subunit, putative |
Toxoplasma gondii | TGME49_242290 | proteasome subunit alpha1, putative |
Theileria parva | TP04_0366 | proteasome subunit alpha, putative |
Trichomonas vaginalis | TVAG_267300 | Family T1, proteasome alpha subunit, threonine peptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.1250 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.1250 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.1250 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.1250 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C15H11.7 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C15H11.7 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C15H11.7 | Caenorhabditis elegans | slow growth | wormbase |
YGL011C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1223100 | Plasmodium berghei | Essential | plasmo |
TGME49_242290 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | proteasome (prosome, macropain) subunit, alpha type, 6 | Compounds | References |